National Storage Mechanism | Additional information
RNS Number : 6821Q
Societe Generale SA
01 March 2021
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGSBY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING1% OR MORE

 

1.       KEY INFORMATION

 

Name of person dealing (Note 1)

Société Générale S.A.

Company dealt in

               Willis Towers Watson plc

Class of relevant security to which the dealings being disclosedrelate (Note 2)

US$0.000304635 ordinary shares

Date of dealing

26/02/2021

 

2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

798,059

0.62

1,593

0.00

(2) Derivatives (other than options)

1,434

0.00

8,131

0.01

(3) Options and agreements to purchase/sell

0

0.00

0

0.00

Total

*2,031,553

*1.58

9,724

0.01

                               

* Include the holding of shares 1,232,060 on borrow products

 

               

(b)        Interests and short positions in relevant securities of thecompany, other than the class dealt in (Note 3)

 

Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

 

 

 

 

(2) Derivatives (other than options)

 

 

 

 

(3) Options and agreements to purchase/sell

 

 

 

 

Total

 

 

 

 

 

 

Ap20

 

 

1.       DEALINGS (Note 4)

 

(a)      Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit USD (Note 5)

Purchase

42

221.59

Purchase

42

221.63

Purchase

100

221.51

Purchase

172

224

Purchase

30

220.87

Purchase

19

220.87

Purchase

168

224

Purchase

8

220.87

Purchase

8

222.71

Purchase

19

221.03

Purchase

100

222.52

Purchase

12

220.65

Purchase

12

221.72

Purchase

90

222.71

Purchase

2

222.71

Purchase

42

223.07

Purchase

42

222.65

Purchase

42

222.45

Purchase

42

222.48

Purchase

42

222.47

Purchase

48

220.64

Purchase

42

221.45

Purchase

42

221.54

Purchase

42

221.44

Purchase

42

223.12

Purchase

42

222.71

Purchase

42

221.61

Purchase

42

222.94

Purchase

42

223.04

Purchase

42

223.04

Sale

12

220.96

Sale

13

221

Sale

18

222.03

Sale

100

222.69

Sale

40

222.25

Sale

10

222.25

Sale

50

222.25

Sale

7,118

220.64

Sale

695

220.64

Sale

3

220.55

Sale

10

220.55

Sale

100

223.65

Sale

100

220.71

Sale

9

220.64

Sale

105

220.68

Sale

10

220.75

Sale

15

220.71

Sale

42

220.71

Sale

150

220.72

Sale

18

220.71

Sale

126

220.69

Sale

24

220.51

Sale

38

220.69

Sale

100

220.64

Sale

160

220.64

Sale

1

221.89

Sale

15

221.89

Sale

100

222.68

Sale

304

220.64

Sale

2,280

220.64

Total Purchases

1,460

 

Total Sales

11,766

 

 

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit USD

(Note 5)

Euro Medium Term Note

Increased long

6

0.1319

 

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2.       OTHERINFORMATION

 

Agreements, arrangementsor understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and 

any other person relating to the voting rights of any relevant securities under any option referred to 

on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to 

which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)                                            No

 

Date of disclosure

01/03/2021

Contact name

Société Générale - Disclosure team

Telephone number

+33 1 42 14 92 74

If a connectedEFM, name of offeree/offeror with which connected

 

If a connectedEFM, state nature of connection (Note 10)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEFLFIIVIILIIL